Sign inJoin waitlistJoin the waitlist

Melody Cobleigh

Professor, Department of Internal Medicine, Division of Hematology, Oncology and Cell Therapy · Rush University Medical Center

Credentials: · · · ·

History

Rush University Medical Center
Present
Rush University Medical Center
Present

Indiana University School of Medicine
1979–1981
Internal Medicine
Rush University Medical Center
1976–1979
Rush Medical College
1972–1976

Research

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer
Journal of Clinical Oncology · 2002 · 2,488 citations
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
New England Journal of Medicine · 2007 · 2,445 citations
Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after…
Journal of Clinical Oncology · 1999 · First of 11 authors · 2,255 citations

Dennis Slamon
11 papers
Kathy Miller
11 papers
CV
Charles Vogel
9 papers
Lydia Usha
9 papers
LF
Louis Fehrenbacher
8 papers
SS
Steven Shak
8 papers
Hope Rugo
7 papers
JG
Julie Gralow
7 papers
Ruta Rao
7 papers
Thomas Lad
7 papers
Eric Winer
6 papers
George Sledge
6 papers

Grants

Biomedical Research Support Grant
National Center for Research Resources · S07
Project lead · Illinois Cancer Center

Clinical trials

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Principal investigator · Completed · Phase 3
National Cancer Institute (NCI)
2008–2025
Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Study chair · Completed · Phase 3
Eastern Cooperative Oncology Group
2002–2009
Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer
Study chair · Completed · Phase 3
Eastern Cooperative Oncology Group
2000–2007
Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer
Study chair · Completed · Phase 3
Eastern Cooperative Oncology Group
1995